Elite in Paget's Disease of Bone

William D. Fraser

Norwich Research Park, 
Norwich, ENG, GB 
Elite in Paget's Disease of Bone
Norwich Research Park, 
Norwich, ENG, GB 
OverviewLocationsClinical Research

Overview

William Fraser practices in Norwich, United Kingdom. Mr. Fraser is rated as an Elite expert by MediFind in the treatment of Paget's Disease of Bone. His top areas of expertise are Paget's Disease of Bone, Malnutrition, Preeclampsia, and Hypoparathyroidism.

His clinical research consists of co-authoring 298 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Paget's Disease of Bone.

Gender
Male

Locations

Norwich Research Park, Norwich, ENG, United Kingdom
Other Locations
Colney Lane, Norwich, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Other
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
Enrollment Status: Completed
Publish Date: September 17, 2025
Intervention Type: Drug
Study Drugs: Teriparatide, Zoledronic Acid
Study Phase: Phase 4
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4
View 2 Less Clinical Trials

298 Total Publications

The Influence of Solar-Simulated UV Radiation on Circulating 25(OH)D3, 24,25(OH)2D3 and Their Ratio in Younger and Older Adults.
The Influence of Solar-Simulated UV Radiation on Circulating 25(OH)D3, 24,25(OH)2D3 and Their Ratio in Younger and Older Adults.
Journal: Nutrients
Published: May 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fraser's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile